Tactorum

Tactorum is a biotechnology company transforming how pain is measured in preclinical research. Our flagship product, the ARM (Automated Reproducible Mechano-stimulator) technology benefits both scientific research and patient health by closing a critical gap in how pain is measured. For researchers, ARM provides a standardized, objective way to quantify pain responses in preclinical models, improving data quality, reproducibility, and experimental efficiency. It reduces bias, increases throughput, and enables more precise modeling of pain mechanisms—accelerating the development and testing of new therapies. For patients, these improvements translate into faster, more reliable identification of effective treatments, especially non-opioid alternatives. By producing high-quality data with greater translational value, ARM helps ensure that preclinical findings are more likely to succeed in human clinical trials. In the long term, this leads to better pain diagnostics and targeted interventions, ultimately improving patient outcomes and quality of life.